Werbung
Werbung
IRD
I
Opus Genetics, Inc. Common Stock
1.94
USDGesponsert
-0.06
-3.25%
09. Jan., 15:32 UTC -5
Geschlossen
Nach-Markt
1.94
0.00
0.00%
IRD Ergebnisberichte
Positives Überraschungsverhältnis
IRD übertreffen die 25 der letzten 36Schätzungen.
69%
Nächster Bericht
Datum des nächsten Berichts
30. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$3.31M
/-$0.12
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+7.53%
/-52.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-23.04%
/-45.45%
Opus Genetics, Inc. Common Stock earnings per share and revenue
On 12. Nov. 2025, IRD reported earnings of -0.25 USD per share (EPS) for Q3 25, missing the estimate of -0.13 USD, resulting in a -90.40% surprise. Revenue reached 3.08 million, compared to an expected 3.11 million, with a -0.87% difference. The market reacted with a -2.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.12 USD, with revenue projected to reach 3.31 million USD, implying an decrease of -52.00% EPS, and increase of 7.53% in Revenue from the last quarter.
FAQ
What were Opus Genetics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Opus Genetics, Inc. Common Stock reported EPS of -$0.25, missing estimates by -90.4%, and revenue of $3.08M, -0.87% below expectations.
How did the market react to Opus Genetics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.54%, changed from $1.97 before the earnings release to $1.92 the day after.
When is Opus Genetics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 30. März 2026.
What are the forecasts for Opus Genetics, Inc. Common Stock's next earnings report?
Based on 10
analysts, Opus Genetics, Inc. Common Stock is expected to report EPS of -$0.12 and revenue of $3.31M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung